Last reviewed · How we verify

NCT05911646: OSA-18

OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?

Recruiting now NA Last updated 8 April 2025
What this trial tests

NA trial testing OSA-18 Survey in Apnea, Obstructive Sleep in 130 participants. Currently enrolling.

Timeline
2 June 2021
Primary endpoint
31 January 2026
31 January 2026

Quick facts

Lead sponsorConnecticut Children's Medical Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment130
Start date2 June 2021
Primary completion31 January 2026
Estimated completion31 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Connecticut Children's Medical Center

Who can join

Adults 3 to 12, any sex, with Apnea, Obstructive Sleep or Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The concept is a novel research idea that incorporates the potential impact of patient quality of life (QOL) on decision-making for treatment of mild obstructive sleep apnea (OSA). Our hypothesis is that in children with mild OSA there is significant conflict with parental decision-making; in the absence of significant sleep apnea, there is limited research regarding comparative efficacy of various treatment options. The impact of a QOL questionnaire can be a significant deciding factor and may help guide management decisions in such situations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Apnea, Obstructive Sleep

Currently open trials in the same condition.

Other Connecticut Children's Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05911646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing